Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de5ba9cb3f8c619d1d50851552c258bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b04f0bbc03c49a1040fc1ef91aa48114 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f234c5e6446938b4ab9d08074c3121b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7acfa8a0866dfe3f8db63dae21fab907 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40be94296e3add7ac25065391cebb511 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7115 |
filingDate |
2004-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56798054d46c1f6d3a9aa06133d084e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3b89c4f4f3b77d5b49240f9efdfea77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cf82bac164c427d8c2eead013336957 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6c2403b7dbda3fa8dbc68bf09f15b32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b611c43fb76a4f8540caeb39ca0d8354 |
publicationDate |
2005-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2005083071-A1 |
titleOfInvention |
Polynucleotide participating in rheumatoid arthritis and utilization of the same |
abstract |
Analysis is made on the DNA methylation of the region (including a promoter region) upstream from the initiation point of a rheumatoid arthritis-associated gene DR3 in human genome. As a result, it is found out that an allele-specific methylation occurs in a CpG sequence located about -380 to -180 bp upstream from initiation point (ATG) of the gene DR3. It is further found out that the CpG sequences downstream therefrom of the genes DR3 originating in healthy subjects are all in the unmethylated state, while methylated and unmethylated sequences are both observed in the genes DR3 originating in RA patients. |
priorityDate |
2004-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |